ERASCA, INC. (ERAS)
Clinical trial NCT04866134 updates: 1. completion date: 2025-11-01 → 2027-01-01 2. primary completion date: 2025-05-01 → 2026-11-01
Clinical trial NCT04866134 updates: 1. completion date: 2025-11-01 → 2027-01-01 2. primary completion date: 2025-05-01 → 2026-11-01
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical